Warner Chilcott Company LLC.

Filed match against Warner Chilcott on December 24, 2013, in the U.S. District Court for the District of Delaware wanting to prevent Actavis from commercializing its ANDA product before the expiration of U.S. Patent No 5,989,581.S. Sales of around $560 million, according to IMS Health data.. Actavis’ subsidiary files ANDA for generic edition of NuvaRing Actavis plc today confirmed that its subsidiary, Warner Chilcott Company LLC, has filed an Abbreviated New Medication Application with the U.S. Food and Medication Administration seeking approval to advertise Ethinyl Estradiol and Etonogestrel Vaginal Ring, 0.015 mg/24 hour and 0.12 mg/24 hour. Related StoriesAlnylam presents positive ongoing stage 2 open-label expansion data for Patisiran and RevusiranAllergan settles patent litigation with Amneal linked to NAMENDA XR extended release capsulesMylan sued in connection with ANDA submitting for generic edition of Zytiga Merck Sharp & Dohme B.V.Secretary-General Ban Ki-moon met with 30 major pharmaceutical manufacturers and said solidarity – meaning that all have access to medicines and vaccines – was needed. The only major drug maker that publicly decided to the WHO demand Tuesday was Britain’s GlaxoSmithKline PLC, which stated it would donate 50 million doses in a pandemic and offer more that WHO could purchase at a price cut for poor countries. Another drug maker with just limited production capability said it would share half of its vaccine dosages.